Your Location：
Home >
Browse articles >
Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter
Updated：2026-03-12
Previous|Next

    • Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter

    • Military Medical Research Vol. 0, Issue 3, Pages: 178-182(1998)

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

6

Views

9

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition
Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
Ionizable drug delivery systems for efficient and selective gene therapy
Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Related Author

Guang-Tong Deng
Xiang Chen
Fu-Rong Zeng
Ming-Zhu Yin
Hui Su
Yi-Huang Liu
Qian Zhou
Yi He

Related Institution

Department of Oncology, Xiangya Hospital, Central South University
Department of Breast Reconstruction, Tianjin Medical University Cancer Institute and Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University
Furong Laboratory